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ABSTRACT 
 
 
Howard, Leah Ann. M.S.B.M.E., Purdue University, May 2012. A Novel Furanone-
Containing Antibacterial System for Improved Dental Restoratives. Major Professor: 
Dong Xie. 
 
 
The furanone derivatives and their constructed polymers were synthesized, 
characterized and formulated into dental glass-ionomer cement (GIC) and resin 
composite for improved antibacterial properties. Compressive strength (CS) and S. 
mutans viability were used to evaluate the mechanical strength and antibacterial activity 
of the restoratives. Fuji II LC cement and P60 were used as control. The specimens were 
conditioned in distilled water at 37 oC for 24 h prior to testing. The effects of loading, 
saliva and aging on CS and S. mutans viability were investigated. The antibacterial effect 
of the furanone derivative on other bacteria was also studied. 
 
Chapter 2 describes how we studied and evaluated the formulated antibacterial 
glass-ionomer cement by incorporating the synthesized furanone derivative-containing 
polymer into the formulation. The results show that all the formulated furanone-
containing cements showed a significant antibacterial activity, accompanying with an 
initial CS reduction. Increasing loading significantly enhanced antibacterial activity but 
reduced the initial CS of the formed cements. The derivative showed a broad antibacterial 
spectrum on bacteria including S. mutans, lactobacillus, S. aureus and S. epidermidis. 
Human saliva did not affect the antibacterial activity of the cement. The long-term aging 
study indicates that the cements may have a long-lasting antibacterial function.
  
viii 
Chapter 3 describes how we studied and evaluated the formulated antibacterial 
resin composite by incorporating the synthesized furanone derivative into the basic resin 
formulations. The results show that the modified resin composites showed a significant 
antibacterial activity without substantially decreasing the mechanical strengths. With 5 to 
30% addition of the furanone derivative, the composite kept its original CS unchanged 
but showed a significant antibacterial activity with a 16-68% reduction in the S. mutans 
viability. Further, the antibacterial function of the new composite was not affected by 
human saliva. The aging study indicates that the composite may have a long-lasting 
antibacterial function. 
 
In summary, we have developed a novel furanone-containing antibacterial system 
for dental restoratives. Both glass-ionomer cement and resin composite have 
demonstrated significant antibacterial activities. The modified experimental glass-
ionomer cement is a promising system because the reduced strength of the cement with 
addition of the furanone-containing polymer is still above those demonstrated by original 
commercial cement Fuji II LC. The modified resin composite shows nearly no reduction 
in mechanical strength after incorporation of the antibacterial furanone derivative. It 
appears that both experimental cement and resin composite are clinically attractive dental 
restoratives that can be potentially used for long-lasting restorations due to their high 
mechanical strength and permanent antibacterial function. 
  
1 
INTRODUCTION 
 
 
1.1  Background 
Long-lasting restoratives and restoration are clinically attractive because they can reduce 
patents’ pain and expense as well as the number of their visits to dental offices [1-4]. In 
dentistry, both restorative materials and oral bacteria are believed to be responsible for 
the restoration failure [2]. Secondary caries is found to be the main reason to the 
restoration failure of dental restoratives including resin composites and glass-ionomer 
cements [1-4]. Secondary caries which often occur at the interface between the 
restoration and the cavity preparation is primarily caused by demineralization of tooth 
structure due to invasion of plaque bacteria (acid-producing bacteria) such as 
Streptococcus mutans (S. mutans) in the presence of fermentable carbohydrates [4]. To 
make long-lasting restorations, the materials should be made antibacterial. Although 
numerous efforts have been made on improving antibacterial activities of dental 
restoratives, most of them have been focused on release or slow-release of various 
incorporated low molecular weight antibacterial agents such as antibiotics, zinc ions, 
silver ions, iodine and chlorhexidine [5-9]. Yet release or slow-release can lead or has led 
to a reduction of mechanical properties of the restoratives over time, short-term 
effectiveness, and possible toxicity to surrounding tissues if the dose or release is not 
properly controlled [5-9]. Materials containing quaternary ammonium salt (QAS) groups 
have been studied extensively as an important antimicrobial material and used for a 
variety of applications due to their potent antimicrobial activities [10-14]. These materials 
are found to be capable of killing bacteria that are resistant to other types of cationic 
antibacterials [15]. The examples of the QAS-containing materials as antibacterials for 
dental restoratives include incorporation of a methacryloyloxydodecyl pyridinium 
bromide as an antibacterial monomer into resin composites [12], use of 
  
2 
methacryloxylethyl cetyl ammonium chloride as a component for antibacterial bonding 
agents [16, 17], addition of quaternary ammonium polyethylenimine nanoparticles into 
composite resins [18, 19], and incorporation of PQAS into GICs [20]. All of these studies 
found that the QAS-containing materials did exhibit significant antibacterial activities. 
However, it has been reported that human saliva can significantly decrease the 
antibacterial activity of the QAS-containing restoratives, probably due to electrostatic 
interactions between QAS and proteins in saliva [21, 22]. Recently, furanone derivatives 
have been found to have strong antitumor [23, 24] and antibacterial functions [25]. 
Therefore, we would like to explore them in dental applications. 
 
 
1.2. Hypothesis and Objectives 
It is our hypothesis that incorporating the synthesized furanone derivative or 
derivative-containing polymer into experimental dental resin composite and/or glass-
ionomer cement would provide a novel route for formulation of novel antibacterial dental 
restoratives. Commercial Fuji II LC, recently developed experimental high-strength 
cement and resin composite were used as controls. The objectives of the study in this 
thesis were to:  
 
(1) synthesize and characterize the furanone derivative and/or derivative-
containing polymer  
(2) formulate the GIC and resin composite with the furanone derivatives  
(3) evaluate the mechanical strengths of the formed restoratives  
(4) evaluate the antibacterial activity of the formulated restoratives.  
 
Chapter 2 mainly describes the synthesis, characterization, formulation and 
evaluation of the GICs composed of the furanone-containing polymer. Chapter 3 mainly 
describes the synthesis, characterization, formulation and evaluation of the resin 
composites composed of the furanone derivative. The effects of loading, saliva, and aging 
time on compressive strength and S. mutans viability were also investigated.
  
3 
2. PREPARATION AND EVALUATION OF A NOVEL FURANONE-CONTAINING 
ANTIBACTERIAL GLASS-IONOMOER DENTAL RESTORATIVE 
 
 
2.1  Introduction 
A furanone derivative and its constructed polyacid were synthesized, 
characterized and formulated into the experimental high-strength cements. Compressive 
strength (CS) and S. mutans viability were used to evaluate the mechanical strength and 
antibacterial activity of the cements. All the formulated furanone-containing cements 
showed a significant antibacterial activity, accompanying with an initial CS reduction. 
The effect of the furanone derivative loading was significant. Increasing loading 
significantly enhanced antibacterial activity but reduced the initial CS of the formed 
cements. The derivative showed a broad antibacterial spectrum on bacteria including S. 
mutans, lactobacillus, S. aureus and S. epidermidis. Human saliva did not affect the 
antibacterial activity of the cement. The long-term aging study indicates that the cements 
may have a long-lasting antibacterial function. Within the limitations of this study, it 
appears that this experimental antibacterial cement is a clinically attractive dental 
restorative due to its high mechanical strength and antibacterial function. 
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2.2  Materials and Methods 
 
 
2.2.1 Materials 
Acrylic acid (AA), glycolic acid (GA), 3,4-dichloro-5-hydroxy-2(5H)-furanone 
(DHF), dipentaerythritol, 2-bromoisobutyryl bromide (BIBB), 2,2’-azobisisobutyronitrile 
(AIBN), triethylamine (TEA), CuBr, N,N,N’,N’,N’’-pentamethyldiethylenetriamine 
(PMDETA), dl-camphoroquinone (CQ), 2-(dimethylamino)ethyl methacrylate 
(DMAEMA), pyridine, tert-butyl acrylate (t-BA), glycidyl methacrylate (GM), 
hydrochloric acid (HCl, 37%), sulfuric acid, pyridine, diethyl ether, dioxane, N,N-
dimethylformamide (DMF), toluene, hexane and tetrahydrofuran (THF) were used as 
received from Sigma-Aldrich Co. (Milwaukee, WI) without further purifications. Light-
cured glass-ionomer cement Fuji II LC and Fuji II LC glass powders were used as 
received from GC America Inc (Alsip, IL). 
 
 
2.2.2 Synthesis and Characterization 
 
 
2.2.2.1  Synthesis of 3,4-dichloro-5-(1,3-glycerol ethylene glycolate methacrylate)-2-
furanone (DGEGM) 
To a solution containing DHF (0.5 mol), toluene and sulfuric acid (1% by mole), 
glycolic acid (0.55 mol) in toluene was added. The reaction was run at 90-100 oC for 3-4 
h until no more water came out. Then toluene was removed using a rotary evaporator. 
The formed 3,4-dichloro-5-(hydroxyacetic acid)-2-furanone (DHAF) was purified by 
washing with sodium bicarbonate and distilled water. After freeze-drying, DHAF (0.5 
mol) was mixed with GM (0.52 mol) and pyridine (3%, by weight) in DMF. The mixture 
was reacted at 50 oC for 8h [27], followed by washing with hexane and diethyl ether and 
drying in a vacuum oven prior to use. The synthesis scheme is shown in Fig. 2.1, part A. 
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2.2.2.2  Synthesis of the Poly(acrylic acid-co-DGEGM) 
The linear poly(acrylic acid-co-DGEGM) or poly(AA-co-DGEGM) was prepared 
following our published procedures [26]. Briefly, to a flask containing a solution of AA 
(0.1 mol) and DGEGM (0.1 mol) in THF, AIBN (1% by mole) in THF was added. After 
the reaction was run under N2 purging at 60 oC for 18 h, the polymer was precipitated 
with diethyl ether, followed by drying in a vacuum oven. The synthesis scheme is shown 
in Figure 2.1, part B. 
 
 
2.2.2.3  Synthesis of the GM-Tethered Star-Shape Poly(acrylic acid) 
The GM-tethered 6-arm star-shape poly(acrylic acid) (PAA) was synthesized 
similarly as described in our previous publication [28]. Briefly, dipentaerythritol (0.06 
mol) in 200 ml THF was used to react with BIBB (0.48 mol) in the presence of TEA 
(0.35 mol) to form the 6-arm initiator. t-BA (0.078 mol) in 10 ml dioxane was then 
polymerized with the 6-arm initiator (1% by mole) at 120 °C in the presence of CuBr 
(3%)-PMDETA (3%) catalyst complex via ATRP. The resultant 6-arm poly(t-BA) was 
hydrolyzed with HCl and dialyzed against distilled water. The purified star-shape PAA 
was obtained via freeze-drying, followed by tethering with GM (50% by mole) in DMF 
in the presence of pyridine (1% by weight) [28]. The GM-tethered star-shape PAA was 
recovered by precipitation from diethyl ether, followed by drying in a vacuum oven at 
room temperature. The scheme for the structure of the 6-arm star-shape PAA is also 
shown in Figure 2.1, part C. 
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Figure 2.1 Synthesis schematic diagram for: A. DGEGM synthesis, B. poly(AA-co-
DGEGM) synthesis, C. structure of the 6-arm star-shaped poly(AA) with pendent 
methacrylates. 
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2.2.2.4  Characterization 
The chemical structures of the synthesized furanone derivatives were 
characterized by Fourier transform-infrared (FT-IR) spectroscopy and nuclear magnetic 
resonance (NMR) spectroscopy. The proton NMR (1HNMR) spectra were obtained on a 
500 MHz Bruker NMR spectrometer (Bruker Avance II, Bruker BioSpin Corporation, 
Billerica, MA) using deuterated dimethyl sulfoxide and chloroform as solvents and FT-IR 
spectra were obtained on a FT-IR spectrometer (Mattson Research Series FT/IR 1000, 
Madison, WI). 
 
 
2.3  Evaluation 
 
 
2.3.1  Cement Sample Preparation for Strength and Antibacterial Tests 
The experimental cements were formulated with a two-component system (liquid 
and powder) [28]. The liquid was formulated with the light-curable star-shape PAA, water, 
0.9% CQ (photo-initiator, by weight) and 1.8% DC (activator). The polymer/water (P/W) 
ratio = 70:30 (by weight). Fuji II LC glass powder was either used alone or mixed with 
the synthesized poly(AA-co-DGEGM) to formulate the cements, where the poly(AA-co-
DGEGM) loading ratio = 1, 3, 5, 7, 10, or 20% (by weight) of the glass and the P/L ratio 
= 2.7 (by weight). 
 
Specimens were fabricated at room temperature according to the published 
protocol [28]. Briefly, the cylindrical specimens were prepared in glass tubing with 
dimensions of 4 mm in diameter by 8 mm in length for compressive strength (CS), 4 mm 
in diameter by 2 mm in length for diametral tensile strength (DTS), and 4 mm in diameter 
by 2 mm in depth for antibacterial tests. The rectangular specimens were prepared in a 
split Teflon mold with dimensions of 3 mm in width by 3 mm in thickness by 25 mm in 
length for flexural strength (FS) test.  All the specimens were exposed to blue light 
(EXAKT 520 Blue Light Polymerization Unit, EXAKT Technologies, Inc., Oklahoma 
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City, OK) for 2 min, followed by conditioned in 100% humidity for 15 min, removed 
from the mold and conditioned in distilled water at 37 oC for 24 h unless specified, prior 
to testing. 
 
 
2.3.2  Strength Measurements 
CS, DTS, and FTS were performed on a screw-driven mechanical tester (QTest 
QT/10, MTS Systems Corp.). The crosshead moved at a speed of 1mm/minute. The FS 
test was performed with three-point bending with a span of 20 mm between each support. 
In order to obtain a mean value for each material or formulation, six to eight specimens 
were tested. . CS was calculated using an equation of CS = P/πr2, where P = the load at 
fracture and r = the radius of the cylinder. DTS was determined from the relationship 
DTS = 2P/πdt, where P = the load at fracture, d = the diameter of the cylinder, and t = the 
thickness of the cylinder. FS was obtained using the expression FS = 3Pl/2bd2, where P = 
the load at fracture, l = the distance between the two supports, b = the breadth of the 
specimen, and d = the depth of the specimen. 
 
 
2.3.3  Antibacterial Test 
For the antibacterial test published procedures were followed closely [20]. The 
main bacteria used to evaluate the antibacterial activity of the glass ionomer was S. 
mutans. Three other strains of bacteria; lactobacillus, Staphylococcus aureus (S. aureus), 
and Staphylococcus epidermidis (S. epidermidis), were used to demonstrate and evaluate 
the broad antibacterial activity of the glass ionomer material.  
 
One or two colonies of S. mutans (or the other bacteria) from an agar plate were 
suspended in 5 mL of tryptic soy broth (TSB) for 24 hours and incubated at 37⁰C. 
Material specimen samples were pretreated with ethanol for approximately 10 seconds, 
and then incubated with the bacteria in TSBS (TSB supplemented with 1% sucrose) at 
37⁰C for 48 hours under 5% CO2. The specimens were then taken out and the bacteria 
9 
 
 
and TSBS mixture was vortexed and sonicated to break up any bacterial clumps. Equal 
volumes of the red and green dyes from the LIVE/DEAD BacLight bacterial viability kit 
L7007 from Molecular Probes, Inc. were combined and mixed for 1 minute. Next, 3 µL 
of the dye mixture was added to 1 mL of the bacteria suspension, mixed by vortexing for 
10 seconds, sonicated for 10 seconds, and then vortexed for another 10 seconds. The 
mixture was kept in the dark for about 15 minutes prior to analysis. Finally, 20 L of the 
stained bacterial suspension was put onto a microscope slide and analyzed using the 
Nikon Microphot-FXA fluorescent microscope. Triple replica was used to obtain a mean 
value for each material.  
 
 
2.3.4  Saliva Effect Test 
Human saliva was obtained from a healthy volunteer, and the collected saliva was 
centrifuged for 15 minutes at 12,000g to remove debris [21]. The resulting supernatant 
from the centrifuged saliva was filtered with a 0.45 µm sterile filter.  The filtrate was 
stored in 1 ml aliquots in a -20⁰C freezer prior to use. 
 
The sterilized cement specimen was incubated in a small tube containing 1 ml of 
saliva at 37⁰C for 2 hours. The specimen was then taken out of the saliva and used for 
antibacterial testing in the same procedures as described in section 2.3.3. 
 
 
2.3.5  Aging of the Specimens 
In order to analyze the effect of aging on the specimens, those that would be used 
for both CS and antibacterial testing were conditioned in distilled water at 37⁰C for 1 day, 
3 days, 7 days, and 30 days. After being aged in the water, the procedure for testing 
follows the same steps as described in sections 2.3.2 and 2.3.3. 
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2.3.6  Statistical Analysis 
One-way analysis of variance (ANOVA) with the post hoc Tukey-Kramer 
multiple-range test was used to determine significant differences of mechanical strength, 
antibacterial and pulp cell viability tests among the materials or formulations in each 
group. A level of α = 0.05 was used for statistical significance. 
 
 
2.4  Results 
  
 
2.4.1  Characterization 
Table 2.1 shows the FT-IR peaks (cm-1) for GA, DHF, DHAF, GM and DGEGM. 
The disappearance of the peak at 3362 for pseudo hydroxyl group on pseudo ester and 
appearance of the two new peaks at 1810 and 1768 for the carbonyl groups from pseudo 
ester and GA ester as well as a broad COOH peak at 3650-2500 confirmed the formation 
of DHAF. The disappearance of the broad carboxylic acid peak at 3650-2500 and 
appearance of 3480 (OH), 3001-2930 (CH3), 1786, 1742 and 1720 (C=O from pseudo 
ester, GA ester and methacrylate), and 1638 and 1620 (C=C on methacrylate and pseudo 
ester) confirmed the formation of DGEGM. Table 2.2 shows the 1HNMR chemical shifts 
(ppm) for GA, DHF, DHAF, GM and DGEGM. All the new chemical shifts shown in 
Table 2.2 for DGEGM confirmed the formation of DGEGM. 
 
 
2.4.2  Evaluation 
Figures 2.2 (a and b) show the effect of the DGEGM-containing polymer content 
on CS and S. mutans viability of the cements. Both the mean CS and S. mutans viability 
values decreased with an increase in the furanone-containing polymer content. There 
were no statistically significant differences between 1% and 3% for CS and between 0% 
and 1%, 1% and 3%, and 7% and 10% for the S. mutans viability (p>0.05). The DGEGM 
addition showed a reduction of 19-75% for CS and 3-50% for the S. mutans viability. 
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Figure 2.2. Effect of the poly(AA-co-DGEGM) content on CS and S. mutans viability of 
the experimental cements:  
a. Effect on CS;   
b. Effect on the S. mutans viability. MW of the 6-arm poly(acrylic acid) = 17,530 Daltons; 
Filler = Fuji II LC or Fuji II LC + poly(AA-co-DGEGM); Grafting ratio = 50%; P/L ratio 
= 2.7; P/W ratio = 70:30; For CS, specimens were conditioned in distilled water at 37 oC 
for 24 h prior to testing. For S. mutans viability, specimens were conditioned in distilled 
water at 37 oC for 24 h, followed by incubating with S. mutans before antibacterial 
testing. 
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Figure 2.3 shows the effect of the DGEGM-containing cement aging on CS and S. 
mutans viability. After 30-day aging in water, the cement showed a significant CS 
increase (26%) for 7% DGEGM addition. However, no statistically significant changes 
were found in the S. mutans viability for the cement. 
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Figure 2.3. Effect of aging on CS and S. mutans vialibility of the experimental cements: 
The formulations were the same as those described in Figure 2.2, except for the poly(AA-
co-DGEGM) content = 7%. Specimens were conditioned in distilled water at 37 oC for 1, 
7, 14 and 30 days prior to testing. 
 
Figure 2.4 shows the effect of the DGEGM-containing polymer content on the 
viability of four bacteria including S. mutans, lactobacillus, S. aureus and S. epidermidis. 
Increasing DGEGM decreased the viability of all the bacteria, where there were no 
statistically significant differences in viability between 7% and 10% for S. mutans, 
between 5% and 7% for lactobacillus and between 10% and 20% for S. epidermidis (p > 
0.05). With 20% of DGEGM addition, the viability of all four bacteria decreased to 47%. 
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Figure 2.4. Effect of the poly(AA-co-DGEGM) content on the viability of different 
bacteria after culturing with the experimental cements: The formulations were the same 
as those described in Figure 2.2. Specimens were conditioned in distilled water at 37 oC 
for 24 h, followed by incubating with bacteria before antibacterial testing. 
 
Figure 2.5 shows the effect of human saliva on the S. mutans viability after 
culture with the antibacterial cements. There were no statistical differences in the 
viability found between cements with and without human saliva treatment. 
 
Table 2.3 shows the property comparison among the cements with 0%, 5% and 
7% of DGEGM addition. As compared to the cement (0% DGEGM), the cements with 
5% and 7% DGEGM showed a decrease in all the measured strengths. The yield strength 
(YS), compressive modulus (M), CS, diametral tensile strength (DTS), flexural strength 
(FS) showed 16-27%, 3-11%, 31-41%, 13-20% and 29-32% decreases, respectively, 
among which CS and FS showed more reductions. The S. mutans viability also showed a 
significant decrease with 19-28% reduction. 
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Figure 2.5. Effect of human saliva on the S. mutans viability after culturing with the 
cements: The formulations were the same as those described in Figure 2.2. Specimens 
were soaked in human saliva at 37 oC for 2 h, followed by incubating with S. mutans 
before antibacterial testing. 
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2.5  Discussion 
Furanone-containing materials are reported to have a broad range of biological 
and physiological properities, including antitumor, antibiotic, haemorrhagic, fungicidal, 
and insecticidal activities[23-25]. Although it is known that furanones do have these 
antibacterial properties, the biological mechanism in how these derivatives work is still 
under investigation [25]. To explore the application of these compounds in dental 
research, we synthesized a novel furanone rerivative and applied it to dental GICs. The 
following discussion demonstrates how the newly synthesized DGEGM was incorporated 
into our experimental GICs and its effect on the mechanical and antibacterial properties 
of the formed cements. 
 
Figure 2.2 shows the effect of the DGEGM-containing polymer content on CS 
and S. mutans viability of the cements. It is apparent that with DGEGM addition the 
cement showed a decrease in CS and S. mutans viability. The cements lost 19-75% of its 
original CS value (325 MPa) with 1-20% DGEGM addition, among which the cements 
with 5 and 7% DGEGM showed a 30-40% loss but the values were still close to 200 
MPa. The loss of CS can be attributed to the incorporated DGEGM because hydrophobic 
DGEGM did not contribute any strength enhancement to the cements. Regarding the S. 
mutans viability, DGEGM significantly increased the antibacterial activity of the cement. 
With 1-20% DGEGM addition, the S. mutans viability was reduced from 3 to 50%, 
among which the cements with 5 and 7% DGEGM showed a 19-28% reduction. 
Considering the feasibility of GICs applied in dental clinics, the CS value below 200 
MPa may not be well acceptable because the CS values of most commercially available 
light-cured GICs are in the range of 180-240 MPa [5, 29]. Therefore, the cements with 5 
and 7% DGEGM addition were chosen to evaluate other properties. 
 
It is well known that GICs increase their strengths with time due to constant salt-
bridge formations [30]. To confirm if the DGEGM-modified GIC still follows the pattern 
that most GICs have, we examined both CS and antibacterial function of the cements 
after aging in water for 1 day, 7 days, 14 days and 30 days. The result in Fig. 3 shows that 
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the cements with 7% DGEGM showed 26% increase in CS after 30-day aging in water 
and no changes in the S. mutans viability were found. The reason can be attributed to the 
fact that the DGEGM-containing polymer is a copolymer of acrylic acid and DGEGM. It 
is known that the carboxylic acid group plays a key role in GIC setting and salt-bridge 
formation. The DGEGM-containing polymer not only provided antibacterial function but 
also supplied carboxyl groups for salt-bridge formation. The latter helped the polymer 
firmly attached to the glass fillers. The results also imply that the DGEGM-containing 
polymer did not leach out of the cement. 
 
As stated before, lactobacillus is another main oral cavity-producing bacterium 
although it is not as popular as S. mutans. S. aureus and S. epidermidis are two major 
bacteria that often cause skin and other implant infections. To examine the antibacterial 
activity of DGEGM on these bacteria, we compared the viability of all the four bacteria 
after incubating with the cements. The result in Figure 4 shows that no statistically 
noticeable differences in viability were found among the four bacteria, even though the 
absolute values were different from one another. Increasing the DGEGM-containing 
polymer content significantly decreased the viability of all the bacteria, indicating that the 
DGEGM-containing polymer is a polymer with a broad antibacterial spectrum. 
 
Figure 2.5 shows the effect of human saliva on the S. mutans viability after 
culturing with the DGEGM –containing cements. No statistically significant differences 
in the S. mutans viability were found between the cements with and without human saliva 
treatment. It has been noticed that saliva can significantly reduce the antibacterial activity 
of the QAS or PQAS-containing materials based on the mechanism of contact inhibition 
[21, 22]. The reduction was attributed to the interaction between positive charges on QAS 
or PQAS and amphiphilic protein macromolecules in saliva, thus leading to formation of 
a protein coating which covers the antibacterial sites on QAS or PQAS [21, 22]. Unlike 
QAS or PQASA, DGEGM does not carry any charges. That may be why the DGEGM-
modified cements did not show any reduction in antibacterial activity after treating with 
saliva. 
20 
 
 
Finally we compared YS, M, CS, DTS, FS and the S. mutans viability of the 
cements having 0, 5 and 7% of DGEGM. As shown in Table 2.3, the DGEGM-modified 
cements were 16-17% in YS, 3.6-11% in modulus, 31-41% in CS, 13-20% in DTS and 
29-32% in FS lower than the cement without DGEGM addition. On the other hand, the 
DGEGM-modified cements were much higher (19 and 28% higher) in antibacterial 
activity than the cement without DGEGM addition. 
 
 
2.6  Conclusions 
The dental restorative material developed and evaluated is a novel furanone-
containing antibacterial glass-ionomer cement. All of the furnanone-modified cements 
show significant antibacterial activity, along with an initial reduction in CS strength. 
DGEGM loading had a significant effect on both antibacterial and mechanical strength. 
With an increase in loading, the cement had enhanced antibacterial activity, but an initial 
reduced CS. Modifying the cement with DGEGM showed a broad range of antibacterial 
activity, killing S. mutans, lactobacillus, S. aureus, and S. epidermidis. When coated with 
human saliva, the antibacterial power of the cement was not affected. The long-term 
aging study indicated that the cements have a long-lasting antibacterial function. Because 
of the antibacterial function and strength properties, it appears that the furanone-
containing glass ionomer is a clinically attractive dental restorative.  
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3. PREPARATION AND EVALUATION OF A NOVEL FURANONE-CONTAINING 
ANTIBACTERIAL GLASS-IONOMOER DENTAL RESTORATIVE 
 
 
3.1  Introduction 
A novel furanone-containing antibacterial resin composite has been prepared and 
evaluated. Compressive strength (CS) and S. mutans viability were used to evaluate the 
mechanical strength and antibacterial activity of the composites. The modified resin 
composites showed a significant antibacterial activity without substantially decreasing 
the mechanical strengths. With 5 to 30% addition of the furanone derivative, the 
composite kept its original CS unchanged but showed a significant antibacterial activity 
with a 16-68% reduction in the S. mutans viability. Further, the antibacterial function of 
the new composite was not affected by human saliva. The aging study indicates that the 
composite may have a long-lasting antibacterial function. Within the limitations of this 
study, it appears that the experimental antibacterial resin composite may potentially be 
developed into a clinically attractive dental restorative due to its high mechanical strength 
and antibacterial function. 
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3.2  Materials and Methods 
 
 
3.2.1 Materials 
Bisphenol A glycerolate dimethacrylate (BisGMA), Bisphenol A ethoxylate 
dimethacrylate (BisEMA), urethane dimethacrylate (UDMA), triethylene glycol 
dimethacrylate (TEGDMA), dl-camphoroquinone (CQ), 2-(dimethylamino)ethyl 
methacrylate (DMAEMA), sulfuric acid, toluene, acryloyl chloride (AC), 3,4-
dichloromalealdehydic acid (DA), ethyl acetate and sodium bicarbonate were used as 
received from Sigma-Aldrich Co. (Milwaukee, WI) without further purifications. The 
untreated glass fillers from Herculite XRV (0.7 microns) were used as received from 
Sybron Dental Specialties (Newport Beach, CA). Filtek P-60 resin composite was used as 
received from 3M ESPE (St. Paul, MN). 
 
 
3.2.2 Synthesis and Characterization 
 
 
3.2.2.1. Synthesis of 5-acryloyloxy-3,4-dichlorocrotonolactone (AD) 
To a solution containing DA (0.5 mol) and toluene, AC (0.52 mol) in toluene was 
added. After the mixture was run at 90-100 oC for 3-4 h, toluene was removed using a 
rotary evaporator. The residue was then washed with sodium bicarbonate and distilled 
water, followed by extracting with ethyl acetate. The formed AD was obtained by 
completely removing ethyl acetate using the rotary evaporator before drying in a vacuum 
oven. The synthesis scheme is shown in Figure 3.1. 
 
 
3.2.2.2.  Characterization 
The chemical structure of the synthesized AD and starting chemicals was 
characterized by Fourier transform-infrared (FT-IR) spectroscopy and nuclear magnetic 
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resonance (NMR) spectroscopy. The proton NMR (1HNMR) spectra were obtained on a 
500 MHz Bruker NMR spectrometer (Bruker Avance II, Bruker BioSpin Corporation, 
Billerica, MA) using deuterated dimethyl sulfoxide and chloroform as solvents and FT-IR 
spectra were obtained on a FT-IR spectrometer (Mattson Research Series FT/IR 1000, 
Madison, WI). 
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Figure 3.1. Schematic diagram for the structures of the oligomers used in the study and 
synthesis of AD from the reaction of DA with AC. 
 
 
3.3  Evaluation 
 
 
3.3.1  Cement Sample Preparation for Strength and Antibacterial Tests 
The experimental resin composites were formulated with a two-component system 
(liquid and powder) [20]. The liquid was formulated with the newly synthesized monomer 
AD, BisGMA, UDMA, BisEMA, CQ (photo-initiator) and DMAEMA (activator). AD was 
mixed with a mixture of BisGMA, UDMA and BisEMA (BisGMA/UDMA/BisEMA = 
1:1:1, by weight) in a ratio of AD/a mixture = 0, 5, 10, 20, 30, 40, 50 and 70% (by weight) 
unless specified. CQ (1.0% by weight) and DMAEMA (2.0%) were added for photo-
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initiation. TEGDMA was also used as reference in evaluating viscosities of the formulated 
liquids. The untreated glass Herculite XRV (0.7 microns) powders were used as fillers and 
treated with γ-(trimethoxysilyl)propyl methacrylate, following the published protocol [20]. 
A filler level at 75% (by weight) was used throughout the study unless specified. 
 
Specimens were fabricated by thoroughly mixing the liquid with the treated fillers 
at room temperature according to the published protocol [20]. Briefly, the cylindrical 
specimens were prepared in glass tubing with dimensions of 4 mm in diameter by 8 mm 
in length for compressive strength (CS), 4 mm in diameter by 2 mm in length for 
diametral tensile strength (DTS), and 4 mm in diameter by 2 mm in depth for 
antibacterial tests. The rectangular specimens were prepared in a split Teflon mold with 
dimensions of 3 mm in width by 3 mm in thickness by 25 mm in length for flexural 
strength (FS) test.  All the specimens were exposed to blue light (EXAKT 520 Blue Light 
Polymerization Unit, EXAKT Technologies, Inc., Oklahoma City, OK) for 2 min, 
followed by removing from the mold prior to testing. 
 
 
3.3.2  Strength Measurements 
CS, DTS and FS tests were performed on a screw-driven mechanical tester (QTest 
QT/10, MTS Systems Corp., Eden Prairie, MN), with a crosshead speed of 1 mm/min. 
The FS test was performed in three-point bending with a span of 20 mm between 
supports. Six to eight specimens were tested to obtain a mean value for each material or 
formulation in each test. CS was calculated using an equation of CS = P/πr2, where P = 
the load at fracture and r = the radius of the cylinder. DTS was determined from the 
relationship DTS = 2P/πdt, where P = the load at fracture, d = the diameter of the cylinder, 
and t = the thickness of the cylinder. FS was obtained using the expression FS = 3Pl/2bd2, 
where P = the load at fracture, l = the distance between the two supports, b = the breadth 
of the specimen, and d = the depth of the specimen. 
 
 
25 
 
 
3.3.3  Other Property Determinations 
The viscosity of the formulated liquid was determined at 23 oC using a cone/plate 
viscometer (RVDV-II+CP, Brookfield Eng. Lab. Inc., MA, USA), as described elsewhere 
[26]. For exotherm measurement, the heat generated from the setting reaction of the resin 
composite was determined with a slightly modified ASTM F-451 procedure [26]. Briefly, 
the composite paste was placed in a cylindrical Teflon mold with dimensions of 30 mm in 
diameter by 6 mm in height and covered with a Teflon plunger having holes for allowing 
the excessive paste to escape. A digital thermocouple (Fisher Scientific, Springfield, NJ) 
was inserted into the center of the resin composite and used to record the temperature 
change. The peak temperature was defined as the exotherm. The polymerization 
shrinkage was determined using an equation of % Shrinkage = (1 - duncured/dcured) x 100, 
where dcured is the density of cured composite and duncured the density of uncured 
composite [33]. The densities of the uncured and cured composites were determined by 
weighing the uncured composite paste injected from a calibrated syringe which was used 
to determine the volume of the uncured paste and weighing the cured cylindrical 
specimen whose volume was measured in a calibrated buret in the presence of water, 
respectively. The mean values were averaged from three readings. 
 
 
3.3.4  Antibacterial Test 
The antibacterial test was conducted following the published procedures [31]. S. 
mutans was used to evaluate the antibacterial activity of the studied composites. Briefly, 
one or two colonies of S. mutans were suspended in 5 mL of tryptic soy broth (TSB. 
Specimens pretreated with ethanol (10 s) were incubated with S. mutans in TSB, 
supplemented with 1% sucrose, at 37°C for 48 h under 5% CO2. After equal volumes of 
the red and the green dyes (LIVE/DEAD BacLight bacterial viability kit L7007, 
Molecular Probes, Inc., Eugene, OR, USA) were combined in a microfuge tube and 
mixed thoroughly for 1 min, 3 μL of the dye mixture was added to 1 mL of the bacteria 
suspension, mixed by vortexing for 10 s, sonicating for 10 s as well as vortexing for 
another 10 s, and kept in dark for about 15 min, prior to analysis. Then 20 μL of the 
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stained bacterial suspension was analyzed using a fluorescent microscope (Nikon 
Microphot-FXA, Melville, NY, USA). Triple replica was used to obtain a mean value for 
each material. 
 
 
3.3.5  Saliva Effect Test 
Human saliva, obtained from a healthy volunteer, was centrifuged for 15 min at 
12,000g to remove debris [21]. After the supernatant was filtered with a 0.45-μm sterile 
filter, the filtrate was stored in a -20 oC freezer prior to testing. The sterilized composite 
specimen (see 2.3.4) was incubated in a small tube containing 1 ml of saliva at 37 oC for 
2 h [21], followed by placing in 5 ml TSB supplemented with 1% sucrose. The rest of the 
procedures for antibacterial test are described in 3.3.4. 
 
 
3.3.6  Aging of the Specimens 
The specimens for both CS and antibacterial activity aging tests were conditioned 
in distilled water at 37 oC for 1 day, 3 days, 7 days and 30 days, followed by direct testing 
for CS (see 3.3.2 for details) and incubating with S. mutans for 48 h for antibacterial 
testing (see 3.3.4 for details). 
 
 
3.3.7  Statistical Analysis 
One-way analysis of variance (ANOVA) with the post hoc Tukey-Kramer 
multiple-range test was used to determine significant differences of mechanical strength 
and antibacterial tests among the materials or formulations in each group. A level of α = 
0.05 was used for statistical significance. 
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3.4  Results 
  
 
3.4.1  Characterization 
Figure 3.2 shows the FT-IR peaks (cm-1) for GA, DHF, DHAF, GM and 
DGEGM. The disappearance of the peak at 3362 for pseudo hydroxyl group on pseudo 
ester and appearance of the two new peaks at 1810 and 1768 for the carbonyl groups 
from pseudo ester and GA ester as well as a broad COOH peak at 3650-2500 confirmed 
the formation of DHAF. The disappearance of the broad carboxylic acid peak at 3650-
2500 and appearance of 3480 (OH), 3001-2930 (CH3), 1786, 1742 and 1720 (C=O from 
pseudo ester, GA ester and methacrylate), and 1638 and 1620 (C=C on methacrylate and 
pseudo ester) confirmed the formation of DGEGM. Figure 3.3 shows the 1HNMR 
chemical shifts (ppm) for GA, DHF, DHAF, GM and DGEGM. All the new chemical 
shifts shown in Table 3.2 for DGEGM confirmed the formation of DGEGM. 
 
 
Figure 3.2. FT-IR spectra for DA, AC and AD: (a) DA; (b) AC and (c) AD. 
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Figure 3.3. 1HNMR spectra for DA, AC and AD: (a) DA; (b) AC and (c) AD. 
 
 
3.4.2  Evaluation 
Table 3.1 shows the effects of different oligomer mixtures and filler loading on 
compressive strengths of the experimental resin composites and on viscosity of the resin 
liquid. For the effect of oligomer mixtures, the mean strength value was in the decreasing 
order of: YS (MPa):  BisGMA/UDMA > BisGMA/TEGDMA > BisGMA > 
BisGMA/UDMA/BisEMA > BisGMA/BisEMA; M (GPa): BisGMA/TEGDMA > 
BisGMA/UDMA > BisGMA > BisGMA/UDMA/BisEMA > BisGMA/BisEMA; CS 
(MPa): BisGMA/TEGDMA > BisGMA/UDMA/BisEMA > BisGMA/UDMA > 
BisGMA = BisGMA/BisEMA; Viscosity (cp): BisGMA >> BisGMA/UDMA > 
BisGMA/BisEMA > BisGMA/UDMA/BisEMA > BisGMA/TEGDMA. For the effect of 
filler loading, YS: 3.0 > 2.3 > 3.3 > 2.7; M: 3.0 > 3.3 > 2.7 > 2.3; CS: 3.0 > 3.3 > 2.7 > 
2.3. 
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Figures 3.4 (a and b) show the effect of the AD content on CS and S. mutans 
viability of the experimental composites. For CS (Figure 4a), the mean CS value (MPa) 
was in the decreasing order of 5% > 0% > 10% = 20% = 30% > 40% > 50% > 70%, 
where there were no statistically significant differences among 0%, 5%, 10%, 20% and 
30% and between 40% and 50% (p > 0.05). The AD addition did not change the CS of 
the composites until reaching 40%. From 40% to 70%, CS decreased 11-27% of its 
original value. The viscosity value was in the decreasing order of 0% > 5% > 10% > 20% 
> 30% > 40% > 50% > 70%.  For the S. mutans viability (Fig. 4b), increasing the AD 
content significantly decreased the S. mutans viability. The mean viability values were 
decreased from 82 to 1% with 5 to 70% AD addition and all the values were significantly 
different from each other (p < 0.05). 
 
Figure 3.5 shows the effect of human saliva on the S. mutans viability after 
culturing with the experimental composites. No statistically significant differences in the 
S. mutans viability were found between the experimental composites with and without 
human saliva treatment. 
 
Figures 3.6 (a and b) show the effect of the composite aging in water on CS and S. 
mutans viability. For CS (Figure 6a), After 7-day aging in water, all the composites with 
AD addition showed no statistically significant differences in CS from each other (p > 
0.05), regardless filler loading or aging time. For the S. mutans viability (Figure 3.6b), no 
statistically significant differences (p > 0.05) were found after 7-day aging at the same 
filler loading, although a slight increase was noticed.  
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Figure 3.4. Effect of the AD content on the viscosity of the resin liquid formulations and 
CS as well as S. mutans viability of the experimental composites:  
a. Effect on CS and viscosity;  
b. Effect on the S. mutans viability. AD content (%, by weight) = 
AD/(AD/BisGMA/UDMA/BisEMA), where BiSGMA/UDMA/BisEMA = 1:1:1; The 
filler/resin ratio = 3.0 or 75% (by weight). For CS, specimens were directly used for the 
testing. For the S. mutans viability, specimens were incubated with S. mutans before 
antibacterial testing. 
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Figure 3.5. Effect of human saliva on the S. mutans viability after culturing with the 
composites: The formulations were the same as those described in Figure 3.4. Specimens 
were soaked in human saliva at 37 oC for 2 h, followed by incubating with S. mutans 
before antibacterial testing. 
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Figure 3.6. Effect of aging on CS and S. mutans viability of the experimental composites: 
a. Effect on CS;  
b Effect of aging on CS and S. mutans viability of the experimental composites. The 
formulations were the same as those described in Figure 3.4. Specimens were conditioned 
in distilled water at 37 oC for 1, 3 and 7 days prior to testing. 
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Table 3.2 shows a property comparison of the resin composites with and without 
AD addition. The mean values for yield strength (YS), compressive modulus (M), CS, 
diametral tensile strength (DTS) and flexural strength (FS) were in the decreasing order 
of: YS (MPa): 5% > 0% > 10% > 30%, where 0% and 5% were not statistically 
significantly different from each other (p > 0.05); M (GPa): 5% > 0% > 10% > 30%, 
where 0% and 5% were not statistically significantly different from each other (p > 0.05); 
CS (MPa): 0% = 5% = 10% = 30% (p > 0.05); DTS (MPa): 0% > 5% > 10% > 30%, 
where 0%, 5% and 10% were not statistically significantly different from one another; FS 
(MPa): 0% > 5% > 10% > 30%, where 5% and 10% were not statistically significantly 
different from each other (p > 0.05). The mean values for shrinkage, exotherm and S. 
mutans viability were in the decreasing order of: Shrinkage (%): 30% > 10% > 5% > 0%; 
Exotherm (oC): 30% > 10% > 5% > 0%; S. mutans viability (%): 0% > 5% > 10% > 30%. 
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3.5  Discussion 
To explore the application of these furanone compounds in dental research, we 
synthesized a photocurable furanone rerivative and applied it to dental resin composites. 
The following discussion demonstrates how the newly synthesized AD was incorporated 
into a dental composite formulation and its effect on some mechanical, physical and 
antibacterial properties of the formed dental composite. 
 
It is known that commercially available dental resin composites usually contain 
70-80% inorganic fillers and 20-30% of a liquid mixture of BisGMA and TEGDMA or 
BisGMA with one or two other oligomers including UDMA, BisEMA and TEGDMA [5]. 
In formulating the liquid for resin composites, viscosity is one of the very important 
criteria [5] because it determines what percentage of fillers can be incorporated and what 
properties the formed system might have. During the study, we found that the newly 
synthesized AD has a low viscosity (154 cp), which is just a little bit higher than that for 
TEGDMA (132 cp). To avoid having unexpected low viscosity values and mimic 
commercial resin composite systems, we decided to make a new formulation that 
contains AD while eliminating TEGDMA (commonly used in commercial resin 
composites) [5]. The oligomers including BisGMA, BisEMA and UDMA were used to 
formulate the liquid. While formulating the liquid, we also tested the corresponding CS 
of the formulated composite. As shown in Table 1, the mixture of 
BisGMA/UDMA/BisEMA showed a higher CS and appropriate viscosity value (478 cp). 
With this viscosity, the liquid mixture could be used to formulate with AD without 
changing the viscosity significantly, as compared to the liquid formulation used in 
commercial resin composites (BisGMA/TEGDMA = 345 cp). In fact, the measured 
viscosity values for the liquid formulations composed of AD, BisGMA, BisEMA and 
UDMA (BisGMA/UDMA/BisEMA = 1:1:1) were in the range of 463 to 298 cp 
corresponding to 5-70% AD addition (see Figure 4a).  
 
In order to determine how much fillers should be incorporated into the resin, we 
evaluated the effect of the filler content on CS and found that the filler/liquid ratio of 3.0 
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or 75% showed the highest YS, modulus and CS values (see Table 1). Thus we chose the 
mixture of BisGMA/UDMA/BisEMA and 75% filler to formulate the antibacterial resin 
composites. 
 
Next, we evaluated the effect of the AD content on CS and S. mutans viability of 
the experimental composites. From the results in Fig. 4a, increasing AD did not decrease 
the CS of the composites until reaching 40%. From 40 to 70%, CS decreased 11-27% of 
its original value. For the S. mutans viability (Fig. 4b), increasing the AD content 
significantly decreased the S. mutans viability. The mean viability values were decreased 
from 82 to 1% with 5 to 70% AD addition. Apparently with 30% AD addition, the resin 
composite showed the best antibacterial properties without decreasing CS. In other 
words, the resin composite with 30% AD seemed to be the optimal formulation for this 
new antibacterial dental composite. 
 
Figure 3.5 shows the effect of human saliva on the S. mutans viability after 
culturing with the experimental composites. No statistically significant differences in the 
S. mutans viability were found between the composites with and without human saliva 
treatment. It has been noticed that saliva can significantly reduce the antibacterial activity 
of the QAS or PQAS-containing materials based on the mechanism of contact inhibition 
[21, 22]. The reduction was attributed to the interaction between positive charges on QAS 
or PQAS and amphiphilic protein macromolecules in saliva, thus leading to formation of 
a protein coating which covers the antibacterial sites on QAS or PQAS [21, 22]. Unlike 
QAS or PQASA, AD does not carry any charges. That may be why the AD-modified 
resin composites did not show any reduction in antibacterial activity after treating with 
saliva. 
 
To mimic the resin composites in oral environment, the composites were aged in 
distilled water at 37 oC for 1, 3 and 7 days. The results in Figure 3.6 show that all the 
composites with AD addition showed no statistically significant changes in CS (Fig.5a), 
regardless filler loading or aging time. No statistically significant changes in the S. 
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mutans viability were noticed either. This may indicate that most AD derivatives were 
firmly incorporated into the composites without noticeable leaching.  
 
Finally we measured YS, M, CS, DTS, FS, shrinkage, exotherm and S. mutans 
viability of the resin composites with and without AD addition. As shown in Table 2, the 
composites with 5-30% AD addition were 7-18% in YS, 0-15% in modulus, 0-2% in CS, 
3-22% in DTS, 13-22% in FS and 16-68% in the S. mutans viability lower but 0.13-1.38 
times in shrinkage and 0.14-0.56 times in exotherm higher than the composite without 
AD. All these changes can be attributed to the AD addition. Unlike those dimethacrylates 
used in dental resin composites, AD is a monoacrylate, which can lead to a decrease in 
strengths. With increasing AD, shrinkage and exotherm were increased, which can be 
attributed to the increased quantities of carbon-carbon double bonds (C=C) from AD.     
 
 
3.6  Conclusions 
The dental restorative material developed and evaluated is a novel furanone-
containing antibacterial glass-ionomer cement. All of the furnanone-modified cements 
show significant antibacterial activity, along with an initial reduction in CS strength. 
DGEGM loading had a significant effect on both antibacterial and mechanical strength. 
With an increase in loading, the cement had enhanced antibacterial activity, but an initial 
reduced CS. Modifying the cement with DGEGM showed a broad range of antibacterial 
activity, killing S. mutans, lactobacillus, S. aureus, and S. epidermidis. When coated with 
human saliva, the antibacterial power of the cement was not affected. The long-term 
aging study indicated that the cements have a long-lasting antibacterial function. Because 
of the antibacterial function and strength properties, it appears that the furanone-
containing glass ionomer is a clinically attractive dental restorative.  
 
 
 
39 
 
4.  CONCLUSIONS 
 
 
We have developed a novel furanone-containing antibacterial dental restorative 
system with permanent antibacterial function. The furanone-containing glass-ionomer cement 
showed a significant antibacterial activity, accompanying with an initial CS reduction. The 
furanone-constructed resin composite showed a significant antibacterial activity without 
substantially decreasing the mechanical strengths. For GIC, increasing loading significantly 
enhanced antibacterial activity but reduced the initial CS of the formed cements. The 
derivative showed a broad antibacterial spectrum on bacteria including S. mutans, 
lactobacillus, S. aureus and S. epidermidis. For resin composite, with 5 to 30% addition of 
the furanone derivative, the composite kept its original CS unchanged but showed a 
significant antibacterial activity with a 16-68% reduction in the S. mutans viability. Human 
saliva did not affect the antibacterial activity of both furanone-containing GIC and resin 
composite. The long-term aging study indicates that both antibacterial GIC and resin 
composite may have a long-lasting antibacterial function. Within the limitations of this study, 
it appears that both experimental cement and resin composite are clinically attractive dental 
restoratives that can be potentially used for long-lasting restorations due to their high 
mechanical strength and permanent antibacterial function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF REFERENCES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
LIST OF REFERENCES 
 
 
[1] I.A. Mjor, J.E. Dahl, and J.E. Moorhead, “Placement and replacement of restorations 
in primary teeth,” Acta Odontol Scand., vol. 60, pp. 25-28, 2002.  
 
[2] H. Forss, and E. Widstrom, “Reasons for restorative therapy and longevity of 
restorations in adults,” Acta Odontol Scand, vol. 62, pp. 82-86, 2004. 
  
[3] J. Manhart, F. Garcia-Godoy, R. Hickel, “Direct posterior restorations: clinical results 
and new developments,” Dent Clin North Am, vol 46, pp. 303-339, 2002. 
  
[4] V. Deligeorgi, I.A. Mjor, N.H. Wilson, “An overview of reasons for the placement 
and replacement of restorations,” Prim Dent Care, vol. 8, pp. 5-11. 
 
[5] R.G. Craig and J.M. Power, Restorative Dental Materials, St Louis, MO: Mosby-Year 
Book, Inc., 2002, p. 614-618. 
  
[6] A. Weigand, W. Buchalla, T. Attin, Review on fluoride-releasing restorative 
materials-Fluoride release and uptake characteristics, antibacterial activity and 
influence on caries formation, Dent Mater, vol. 23, pp. 343-362, 2007. 
  
[7] P.W. Osinaga, R.H. Grande, R.Y. Ballester, M.R. Simionato, C.R. Rodrigues, and A. 
Muench, “Zinc sulfate addition to glass-ionomer-based cements: influence on 
physical and antibacterial properties, zinc and fluoride release,” Dent Mater, vol. 19, 
pp.212-217, 2003. 
  
[8] Y. Takahashi, S. Imazato, A.V. Kaneshiro, S. Ebisu, J.E. Frencken, and F.R. Tay, 
“Antibacterial effects and physical properties of glass-ionomer cements containing 
chlorhexidine for the ART approach,” Dent Mater, vol. 22, pp. 467-452, 2006. 
  
[9] K. Yamamoto, S. Ohashi, M. Aono, T. Kokubo, I. Yamada, and J. Yamauchi, 
“Antibacterial activity of silver ions implanted in SiO2 filler on oral streptococci,” 
Dent Mater, vol. 12, pp. 227-229, 1996. 
  
[10] T. Syafiuddin, H. Hisamitsu, T. Toko, T. Igarashi, N. Goto, A. Fujishima, and T. 
Miyazaki, “In vitro inhibition of caries around a resin composite restoration 
containing antibacterial filler,” Biomaterials, vol. 18, pp.1051-1057, 1997.  
 
41 
 
[11] B. Gottenbos, H.C. van der Mei, F. Klatter, P. Nieuwenhuis, and H.J. Busscher, “In 
vitro and in vivo antimicrobial activity of covalently coupled quaternary ammonium 
silane coatings on silicon rubber,” Biomaterials, vol. 23, pp. 1417-1423, 2002. 
 
[12]  P. Thebault, E. Taffin de Givenchy, R. Levy, Y. Vandenberghe, F. Guittard, and S. 
Geribaldi, “Preparation and antimicrobial behavior of quaternary ammonium thiol 
derivatives able to be grafted on metal surfaces,” Eur J Med Chem, vol. 44, pp. 717-
724, 2009. 
 
[13] S. Imazato, R.R. Russell, and J.F. McCabe, “Antibacterial activity of MDPB polymer 
incorporated in dental resin,” J Dent, vol. 23, pp. 177-181, 1995. 
 
[14] H. Murata, “Permanent, non-leaching antibacterial surfaces-2: How high density 
cationic surfaces kill bacterial cells,” Biomaterial, vol. 28, pp. 4870-4879, 2007.  
 
[15] G. Lu, D. Wu, and R. Fu, “Studies on the synthesis and antibacterial activities of 
polymeric quaternary ammonium salts from dimethylaminoethyl methacrylate,” 
React & Funct Polym, vol. 67, pp. 355-366, 2007.  
 
[16] S.B. Lee, R.R. Koepsel, S.W. Morley, K. Matyjaszewski, Y. Sun, and A.J. Russell, 
“Permanent, non-leaching antibacterial sufaces. 1. Synthesis by atom transfer radical 
polymerization,” Biomacromolecules, vol. 5, pp. 887-882, 2004. 
 
[17] F. Li, Z.G. Chai, M.N. Sun, F. Wang, L. Zhang, M. Fang, and J.H. Chen, “Anti-
biofilm effect of dental adhesive with cationic monomer,” J Dent Res, vol. 88, pp. 
373-376, 2009. 
 
[18] F. Li, J. Chen, Z. Chai, L. Zhang, Y. Xiao, M. Fang, and S. Ma, “Effects of a dental 
adhesive incorporating antibacterial monomer on the growth, adherence and 
membrane integrity of Streptococcus mutans,” J Dent, vol. 37, pp. 289-296, 2009. 
 
[19] N. Beyth, I. Yodovin-Farber, R. Bahir, AJ. Domb, and EI. Weiss, “Antibacterial 
activity of dental composites containing quaternanry ammonium polyethylenimine 
nanoparticles against Streptococcus mutans,” Biomaterials, vol. 27, pp. 3995-4002, 
2006.  
 
[20] D. Xie, Y. Weng, X. Guo, J. Zhao, R.L. Gregory, and C. Zheng, “Preparation and 
evaluation of a novel glass-ionomer cement with antibacterial functions,” Dent. Mater, 
vol 27, pp. 487-496, 2011. 
 
[21] S. Imazato, N. Ebi, Y. Takahashi, T. Kaneko, S. Ebisu, and R.R.B. Russell, 
“Antibacterial activity of bactericide-immobilized filler for resin-based restoratives,” 
Biomaterials, vol. 24, pp. 3605-3609, 2003. 
 
 
42 
 
[22] N. Ebi, S. Imazato, Y. Noiri, and S. Ebisu, “Inhibitory effects of resin composite 
containing bactericide-immobilized filler on plaque accumulation,” Dent Mater, vol. 
17, pp. 485-491, 2001. 
 
[23] J.H. Jung, S. Pummangura, C. Chaichantipyuth, C. Patarapanich, PE. Fanwick, CJ. 
Change, and JL. Mclaughlin, “New bioactive heptanes from melodorum fruticosum 
(annonaceae),” Tetrahedron, vol. 46, pp. 5043-5054, 1990. 
 
[24] J.B. Jones, and J.M. Young, “Carcinogenicity of lactones III: The reactions of 
unsaturated 4-lactones with l-cystein,” J Med Chem, vol. 11, pp. 1176, 1968. 
 
[25] E. Lattmann, S. Dunn, S. Niamsanit, and N. Sattayasai, “Synthesis and antibacterial 
activities of 5-hydroxyl-4-amino-2(5H)-furanones,” Bioorg Med Chem Lett, vol. 15, 
pp. 919-921, 2005. 
 
[26] W. Wu, D. Xie, A. Puckett, and J. Mays, “Synthesis and formulation of vinyl-
containing polyacids for improved light-cured glass-ionomer cements,” Eur Polym J, 
vol. 39, pp. 663-670, 2003. 
 
[27] D. Xie, Y. Weng, and J. Zhao, “Alternative methacrylate-tethering methods for resin-
modified glass-ionomer cements,” J Appl Polym Sci, vol. 111, pp. 869-875, 2009. 
 
[28] D. Xie, Y. Yang, J. Zhao, J.G. Park, and J.T. Zhang, “A novel comonomer-free light-
cured glass-ionomer system for reduced cytotoxicity and enhanced mechanical 
strength,” Dent Mater, vol. 23, pp. 994-1003, 2007. 
 
[29] M.A. Cattani-Lorente, V. Dupuis, F. Moya, J. Payan, and J.M. Meyer, “Comparative 
study of the physical properties of a polyacid-modified composite resin and a resin-
modified glass ionomer cement,” Dent Mater, vol. 15, pp. 21-32, 1999. 
 
[30] C.L. Davidson, and I.A. Mjor, Advances in glass-ionomer cements. Chicago, IL: 
Quintessence Publishing Co; 1999. 
 
[31] Y. Weng, X. Guo, V.J. Chong, L. Howard, R.L. Gregory, and D. Xie, “Synthesis and 
evaluation of a novel antibacterial dental resin composite with quaternary ammonium 
salts,” J Biomater Sci Eng, vol. 4, pp. 147-157, 2011. 
 
[32] D. Xie, M. Faddah, and J.G. Park, “Novel amino-acid modified zinc polycarboxylates 
for improved dental cements,” Dent. Mater, vol. 21(8), pp. 739-748, 2005. 
 
[33] D. Xie, F. Feng, I.D. Chung, and A.W. Eberhardt, “A hybrid-zinc-calcium-silicate 
polyalkenoate bone cement,” Biomaterials, vol. 24(16), pp. 2749-2757, 2003. 
